| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |